Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Cedars-Sinai Medical Center
900 participants
Sep 1, 2016
OBSERVATIONAL
Conditions
Summary
This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigators to better categorize groups of patients, understand the underlying etiology of these pathologies, identify markers that are associated with favorable or poor outcomes, and track changes that occur during the natural course of the disease or with treatment. This is a prospective observational study which will use samples from such patients to create this library which can be used to explore these questions in the future.
Eligibility
Inclusion Criteria3
- All patients diagnosed with cerebral vascular disease, regardless of gender, age, ethnicity/race, stage of disease or treatment, are eligible.
- Expected availability of clinical follow up data
- Participants must be willing to provide written, informed consent obtained in accordance with institutional and federal guidelines.
Exclusion Criteria1
- Pregnant women are excluded from the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02910180